Dr. Michael Bristow, President and CEO, ARCA biopharma, Inc. ° 26% reduction in total time spent in AF (p 30% decrease in AF interventions and cardiovascular adverse events (p = 0.008)° 55% lower ...
Dr. Michael Bristow, President and CEO, ARCA biopharma, Inc. Clinically important bradycardia is common in heart failure (HF) patients with persistent or paroxysmal atrial fibrillation (AF) In a Phase ...
Background: Symptomatic prolonged sinus pauses on termination of atrial fibrillation (AF) are an accepted indication for pacemaker implantation. We evaluated the outcome of AF ablation in patients ...
This week the FDA has approved a new smartphone ECG device that is capable of detecting three heart arrhythmias takes the form of the AliveCor KardiaMobile. Designed to detect Atrial Fibrillation ...
The FDA cleared the first six-lead personal electrocardiogram device, which can detect arrhythmias like atrial fibrillation, bradycardia and tachycardia, according to CNET, a consumer electronics ...
Purpose: A meta-analysis was conducted to assess the safety of amiodarone in the prevention of postoperative atrial fibrillation. Methods: A search of the medical literature was conducted to identify ...
A recent editorial article emphasized that the updated 2023 and 2024 guidelines for Atrial Fibrillation (AF) provide major ...
A growing body of evidence suggests that both atrial fibrillation (AF) and right ventricular arrhythmia can be the result of intense exercise among highly trained athletes The risk of AF conferred by ...
The European Society of Cardiology (ESC) wrapped up this year's scientific congress in Barcelona, Spain. The event marked the 20th anniversary of the European Heart Rhythm Association (EHRA). These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback